The New RSV Drug Keeps Babies Out of the Hospital ...Middle East

Time - News
The New RSV Drug Keeps Babies Out of the Hospital
Doctors and parents celebrated the major advances that came in 2023 to treat respiratory syncytial virus (RSV), which sends up to 80,000 children under age five to the hospital each year in the U.S. This year, the U.S. Food and Drug Administration approved two critical ways to reduce the risk of RSV in young kids: a vaccine for pregnant mothers that can protect newborns, and a drug treatment for babies under one year. [time-brightcove not-tgx=”true”] In a study published in the New England Journal of Medicine, researchers report encouraging real-world data that show how effective the drug treatment, nirsevimab (brand name: Beyfortus), can be. The study, which was funded by the dr

Hence then, the article about the new rsv drug keeps babies out of the hospital was published today ( ) and is available on Time ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( The New RSV Drug Keeps Babies Out of the Hospital )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News